Information:
Fel:
ID
33897
Beskrivning
Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01661790
Länk
https://clinicaltrials.gov/show/NCT01661790
Nyckelord
Versioner (1)
- 2019-01-06 2019-01-06 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
6 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Malignant Pleural Effusion NCT01661790
Eligibility Malignant Pleural Effusion NCT01661790
- StudyEvent: Eligibility
Similar models
Eligibility Malignant Pleural Effusion NCT01661790
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Non-Small Cell Lung Carcinoma Advanced | Non-small cell lung cancer recurrent | Non-Small Cell Lung Carcinoma Progressive
Item
patients with advanced recurrent or progressive nsclc proven cytohistologically
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0278517 (UMLS CUI [2])
C0007131 (UMLS CUI [3,1])
C0205329 (UMLS CUI [3,2])
C0205179 (UMLS CUI [1,2])
C0278517 (UMLS CUI [2])
C0007131 (UMLS CUI [3,1])
C0205329 (UMLS CUI [3,2])
Karnofsky Performance Status
Item
karnofsky performance status (kps) ≥60
boolean
C0206065 (UMLS CUI [1])
Life Expectancy
Item
life expectancy ≥ 2 months
boolean
C0023671 (UMLS CUI [1])
Absence Disease Organ Major | Absence Liver diseases Severe | Absence Heart Diseases Severe | Absence Kidney Diseases Severe
Item
no history of severe diseases of major organs including liver, heart, and kidney
boolean
C0332197 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
C0178784 (UMLS CUI [1,3])
C0205164 (UMLS CUI [1,4])
C0332197 (UMLS CUI [2,1])
C0023895 (UMLS CUI [2,2])
C0205082 (UMLS CUI [2,3])
C0332197 (UMLS CUI [3,1])
C0018799 (UMLS CUI [3,2])
C0205082 (UMLS CUI [3,3])
C0332197 (UMLS CUI [4,1])
C0022658 (UMLS CUI [4,2])
C0205082 (UMLS CUI [4,3])
C0012634 (UMLS CUI [1,2])
C0178784 (UMLS CUI [1,3])
C0205164 (UMLS CUI [1,4])
C0332197 (UMLS CUI [2,1])
C0023895 (UMLS CUI [2,2])
C0205082 (UMLS CUI [2,3])
C0332197 (UMLS CUI [3,1])
C0018799 (UMLS CUI [3,2])
C0205082 (UMLS CUI [3,3])
C0332197 (UMLS CUI [4,1])
C0022658 (UMLS CUI [4,2])
C0205082 (UMLS CUI [4,3])
Absence Therapy Intrapleural
Item
no previous intrapleural therapy
boolean
C0332197 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C3282906 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,2])
C3282906 (UMLS CUI [1,3])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Thoracic cavity Hemorrhage | Hemorrhage Systemic
Item
active thoracic cavity or systemic bleeding
boolean
C0230139 (UMLS CUI [1,1])
C0019080 (UMLS CUI [1,2])
C0019080 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
C0019080 (UMLS CUI [1,2])
C0019080 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
Pleural infection | Sepsis
Item
active pleural or systemic infection.
boolean
C0919907 (UMLS CUI [1])
C0243026 (UMLS CUI [2])
C0243026 (UMLS CUI [2])
Hypersensitivity Bevacizumab | Cisplatin allergy
Item
known sensitivity to bevacizumab or cisplatin
boolean
C0020517 (UMLS CUI [1,1])
C0796392 (UMLS CUI [1,2])
C0570702 (UMLS CUI [2])
C0796392 (UMLS CUI [1,2])
C0570702 (UMLS CUI [2])
Refusal to Participate Clinical Trial
Item
refusal to participate in the study.
boolean
C1136454 (UMLS CUI [1,1])
C0008976 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,2])